The NSF has recently debuted a new Fast-Track program for its SBIR and STTR programs.
Read MoreBringing federal funding insights to Wisconsin innovators
Read MoreThe Department of Defense (DoD) is mandated to have SBIR/STTR open topics for many of their component organizations now; largely based...
Read MoreWe often talk about and recommend that our clients get involved in the I-Corp programs that some of the federal agencies have. The National Science Foundation (NSF) and the National Institutes of Health (NIH) are the common ones our clients tend to gravitate to.
It was a pleasure and an honor to be invited to the Patriot Day held at Volk Field and Fort McCoy recently.
You can use the money to build your product, but that is not the primary goal. The goal is to do research to demonstrate you can feasibly solve a problem; building the thing is just one part of the means to that end.
We’ve become aware of a System for Award Management (SAM) registration issue from one of our clients that resulted in them not getting funded.
You’ve done the hard work….at least up until now. You worked for months to polish up your proposal, get the budget together, collect your letters of commercial interest, validated that your company and PI are eligible to receive an SBIR or STTR, and got everything submitted.
We at the CTC have recognized the great opportunities for our Wisconsin companies with the Department of Defense SBIR program.
I occasionally get an email or phone call from a client about getting registered with System for Award Management (SAM), or perhaps renewing their SAM registration.
For those of you interested in NSF applications, note that there have been some significant changes in the last year.
We often work with clients who are developing a technology best suited for a medical application.
Congratulations to Plumb Pharma — CTC client and SBIR Advance awardee — on winning the 2020 Governor’s Business Plan Contest! Plumb Pharma of Madison has developed a platform technology for super-extended-release medications that extends release 3-5 times longer than current medications.